Strong Q2 For Dr Reddy's Amid Shadow Of Plant Woes
This article was originally published in Scrip
Executive Summary
Dr Reddy's Laboratories Ltd reported robust growth for the second quarter ended September, but plant-related concerns appear to weigh on the firm's near-term prospects.